Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer

July 28, 2021
12:00 pm

Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer

UPGRADE umbrella study designed to evaluate UpRi in combination with other therapies, starting with carboplatin
CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

Binance’s $6.3 Billion Hack: How Crypto Insurance Works

October 31, 2026

Illumina (ILMN) Stock Price Drops Despite Strong Q3 Earnings

October 31, 2026

Crypto Exchanges Respond After Record $6.3B Binance Hack Exposes Risks

October 31, 2026

SanDisk (SNDK) Stock Price Sinks Despite Blowout Q1 Earnings

October 31, 2026

$6bn hack by ‘bad actors’ hits crypto exchange Binance

October 31, 2026

Mobileye (MBLY) Stock Price Sinks As Q3 Results Expose Loss Risk

October 31, 2026

Crypto exchanges call for quick moves to bolster defenses after Binance heist | The Mighty 790 KFGO

October 31, 2026

Coinbase (COIN) Stock Price Sinks After Q3 Earnings Profit Surprise

October 31, 2026